Part 3 : How to Connect with US VC Investors

Part 3 : How to Connect with US VC Investors

Enterprise Ireland has teamed up with Daniel Glazer a partner at Wilson Sonsini Goodrich & Rosati, where Daniel leads the New York office’s technology transactions practice and also advises Irish and other European emerging technology companies on US expansion, fundraising and strategic partnership transactions. This series will offer perspectives on setting up a business in the US and considerations for Irish companies looking to raise VC investment from US investors

US Expansion – Setting up the Right Way

How to Connect with US VC Investors

Post written by Daniel Glazer, Wilson Sonsini Goodrich & Rosati and Robert Mollen, Fried Frank Harris Shriver & Jacobson

Irish companies frequently ask us, “how can we meet US venture capital firms and get them to invest in our company?”  This article discusses how to connect with the US VCs that are most likely to be interested in your business.

Research your sector

A key starting point in reaching US VCs is to identify those who are most likely to be interested in you.  These are also the VCs who are likely to be the most useful to you because they can bring critical sector-specific business judgment and networks as well as cash.  So, how can you find them?

First, research the VCs in your sector.  Identify the key firms (and the specific individuals of those firms) that have been active in making investments in your sector and at your stage of investment.   Keep in mind that this may be a double-edged sword: if they have invested in businesses that are your direct competitors, they may be unable or unwilling to invest in you.  That being said, the most successful connections we make are where the emerging company is asking us to knock for them at an open door.

Remember that the US is comprised of numerous different markets and VC communities.  Silicon Valley has the largest and most mature venture capital market, but it is highly competitive and not necessarily the best place for every type of business to seek investment.  Also, early-stage VC investors will want you to locate (often with a founder) in proximity to the investor; Silicon Valley is a very expensive place to do business, with fierce competition for talent.

Consequently, you should keep in mind the following regional alternatives:

  • Biotech                                           Boston/Washington, D.C.
  • Cybersecurity                                 Washington, D.C./New York
  • Media/Games                                 Los Angeles/New York
  • Insurance                                        New York/Chicago
  • Emerging Markets                         Miami/New York
  • Hardware/Enterprise Software       Seattle
  • FinTech/Ad Tech/Publishing         New York
  • Various                                           Austin

Leverage your network

Next, seek advice from your existing investors, industry sources, professional advisors and other contacts who are knowledgeable about your sector. Some business sectors, like cybersecurity, are very specialized, with a limited number of key players; others are more diverse.

Attend conferences, conventions and other programs where those interested in your sector can be expected to attend.  In many cases you will be able to see an attendees’ list from a prior year and determine whether the event has been of interest to investors.   Many such events are very large, of course, and it is difficult to make contact with potential investors unless you have planned out, in advance, how you would propose to do so.   If at all possible, pre-arrange meetings with investors whom you would like to meet, or obtain introductions from other attendees whom you know.

Take advantage of trade missions and other pitch opportunities that may provide useful introductions.  Enterprise Ireland, for example, takes regular trade missions of Ireland-based companies to the US (and elsewhere).  Participation may provide opportunities to meet interested investors and to raise your profile so that investors are contacting you, rather than vice versa.

Recruit angel investors and non-executive and advisory board members who are well-connected in the markets/sectors on which you are focusing and are invested in helping your business succeed.  These key connectors will not only help you attract investment – they may also provide invaluable connections to potential customers and partners, and their participation in your business may enhance your company’s credibility in the market.

In a related point, use your wider network to obtain introductions.  Contacting investors on a “cold call” basis is always very difficult.   Don’t hesitate to ask your professional advisors, mentors, accelerators, investors, board members, government contacts and others to introduce you.

Know your investors

Finally, diligence potential VC investors in the same way as you would expect them to diligence you, and understand the dynamics of the environment in which they operate.  Key questions include:

  • Is their current fund coming to close, such that they are unlikely to make early-stage investments in a new venture?
  • Would an investment in your business be likely to generate, in the relevant time frame for their fund, the kind of return that they need to produce?
  • What will be the impact on you if they invest in your current round and then decide not to invest in your later rounds (particularly if they are a larger and higher-profile fund)?
  • Based on their reputation in the market, are these investors that you would want to play a key role in your business?
  • Are they likely to stand by you if things do not go entirely accordingly to plan?

You should view potential VC investors as partners in a marriage.  Before you spend the time and effort in persuading them to invest, you should determine whether you actually want them to invest!

Daniel Glazer leads the US expansion team, and the NYC Tech Transactions practice, at Silicon Valley-based Wilson Sonsini.  He can be reached at daniel.glazer@wsgr.com.

Robert Mollen advises European companies on US matters at Fried Frank in London.  He can be reached at robert.mollen@friedfrank.com.

Symmetry Surgical announces exclusive US distribution agreement with neoSurgical

Symmetry Surgical announces exclusive US distribution agreement with neoSurgical

NASHVILLE, TN – January 05, 2015 – Symmetry Surgical Inc. (Nasdaq:SSRG) announced today an exclusive distribution agreement in the United States with neoSurgical Limited for its innovative neoClose® Trocar Port Closure System. Symmetry Surgical’s sales representatives in the United States will begin selling the neoClose® System in the first quarter of 2015.NeoClose

neoSurgical received clearance to market neoClose® from the United States Food & Drug Administration (FDA) in 2013 for the closure of trocar ports used in robotic and laparoscopic surgical procedures. Since its pilot release, surgeons and clinicians have commented on the product’s ease-of-use, closing 5 mm to 15 mm trocar ports quickly, with virtually no learning curve. Barry Russell, Chief Executive Officer & Founder of neoSurgical Limited, commented, “neoClose® is the first product launch from neoSurgical and we are pleased to be able to partner with Symmetry Surgical on this agreement to achieve access to the entire U.S. market for our innovative solution for trocar port closure.”

Thomas J. Sullivan, Symmetry Surgical’s President and Chief Executive Officer, said, “We are pleased to enter an exclusive distribution agreement in the United States with neoSurgical for its unique neoClose® Trocar Port Closure System. neoSurgical has received positive physician feedback on the neoClose® system in its pilot launch, which gives us confidence that it will be well received in a national launch. Symmetry Surgical is ideally positioned to drive adoption of the neoClose® System with our U.S. sales force, broad customer relationships and strong complementary product offerings in laparoscopic surgical instruments and accessories.”

Mr. Sullivan added, “The collaboration with neoSurgical and the addition of the neoClose® System is aligned with our growth strategy, which is anchored on expanding our product offerings through distribution agreements with innovative companies, acquisitions into the broader $5 billion single use, re-usable, and re-posable surgical device market and our own new product development. Maintaining focus on executing this strategy will drive growth through our core business and in our new products.”

About neoSurgical
neoSurgical is an award-winning global medical device company focused on providing technical innovation to the surgical devices industry, particularly for those surgeons conducting laparoscopic and minimally invasive surgery (MIS). Winner of the 2014 Kinetic Process Innovation Award and the R&D 100 Award, neoSurgical leverages its in-depth expertise in interpreting surgeons’ needs and converting these needs via an innovative and market led engineering response to deliver compliant devices with the goal to make surgery safer, simpler and superior for both surgeons and their patients. The company’s European headquarters is in Dublin with U.S. headquarters in Boston. More information about neoSurgical can be found at www.neosurgical.com.

About Symmetry Surgical Inc.

Symmetry Surgical is dedicated to developing and delivering high-quality, innovative surgical instruments that meet clinicians’ needs and improve patients’ lives. Our team collaborates with healthcare providers around the world to provide medical devices that exceed our customers’ expectations and provide solutions for today’s needs and tomorrow’s growth. Our rich and diverse history creates one of the industry’s most comprehensive surgical instrument portfolios, which includes our well-known brands such as BOOKWALTER®, GREENBERG®, RILEY™, OLSEN™, ULTRA™, QUAD-LOCK®, FLASHPAK®, RAPIDCLEAN®, OPTI-LENGTH®, CLASSIC® and CLASSIC PLUS®. Symmetry Surgical is headquartered in Nashville, TN. For more information, please visit www.symmetrysurgical.com.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close